University Retina and Macula Associates Trials

University Retina and Macula Associates	Welcome, Profile Billing Logout

University Retina and Macula Associates

Welcome, Profile Billing Logout

0 Trials

3 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Rodriquez, Rosa

ENGOT-EN20, NCT05611931 / 2022-002540-42: Selinexor in Maintenance Therapy After Systemic Therapy for Participants with P53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Jul 2024 - Dec 2024: Top-line data from XPORT-EC trial in participants with TP53 wild type endometrial cancer

Recruiting

220

Europe, Canada, US, RoW

Selinexor, KPT-330, Matching Placebo for selinexor

Karyopharm Therapeutics Inc, GOG Foundation, European Network of Gynaecological Oncological Trial Groups (ENGOT), Belgium and Luxembourg Gynaecological Oncology Group, North Eastern German Society of Gynaecological Oncology, Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies, Spanish Research Group in Ovarian Cancer, The Central and Eastern European Gynecologic Oncology Group, Israeli Society of Gynecologic Oncology, Australia New Zealand Gynaecological Oncology Group

Endometrial Cancer

01/25

01/28

SIGLEC, NCT05839041: A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Active, not recruiting

300

AVD-104, Avacincaptad

Aviceda Therapeutics, Inc.

Geographic Atrophy of the Macula, Macular Degeneration

09/25

09/26

Carlos, Soila